Risperdal is a brand of risperidone, an atypical antipsychotic used to help manage schizophrenia, acute manic or mixed episodes in bipolar I disorder, and irritability associated with autism. By balancing dopamine and serotonin signaling in the brain, it can reduce hallucinations, delusions, agitation, and mood instability. Available as tablets, orally disintegrating tablets (ODT), oral solution, and a long-acting injectable (LAI), Risperdal is typically prescribed and monitored by a clinician to optimize benefits and minimize risks such as drowsiness, weight gain, and movement symptoms. This medication is prescription-only in the United States and should be taken exactly as directed by a licensed healthcare professional.
Risperdal is an atypical antipsychotic widely used to treat schizophrenia in adults and adolescents, acute manic or mixed episodes associated with bipolar I disorder, and irritability linked to autism spectrum disorder. By modulating dopamine D2 and serotonin 5-HT2A receptors, risperidone can help reduce hallucinations, delusions, disorganized thinking, agitation, and mood swings, while improving overall functioning. In autism-related irritability, it can lessen aggression, self-injury, and severe tantrums. Clinicians may also consider risperidone in select off-label contexts—such as augmentation for treatment-resistant depression, severe behavioral disturbances, or tic disorders—when evidence and patient-specific factors support it. Any off-label use should be guided by a specialist who can carefully weigh benefits against risks and monitor for metabolic and neurologic side effects.
Dosing is individualized and should be determined by a clinician. For schizophrenia, adults often start at 1–2 mg daily, titrated by 1 mg increments every 24 hours as tolerated to a typical effective range of 4–6 mg/day, given once or twice daily. Some patients respond to lower doses; doses above 8 mg/day rarely improve efficacy and can raise the risk of extrapyramidal symptoms (EPS). For bipolar mania or mixed episodes, initial dosing commonly begins at 2–3 mg/day, titrated to response. Pediatric dosing is weight- and indication-specific; clinicians use lower starting doses and slower adjustments. Older adults and those with hepatic or renal impairment often require lower starting doses and cautious titration.
Risperdal is available as standard tablets, orally disintegrating tablets that dissolve on the tongue, and an oral solution that can be measured precisely for small doses. A long-acting injectable form (e.g., risperidone microspheres) is administered intramuscularly by healthcare professionals on a scheduled interval and is typically used after oral tolerability has been established. Take Risperdal consistently at the same time each day, with or without food, and do not change your dose or stop abruptly without medical advice, as symptoms can return or worsen.
Tell your clinician about your full medical history, including cardiovascular disease, stroke risk, diabetes or prediabetes, seizures, Parkinson’s disease, dementia, liver or kidney problems, low white blood cell counts, and any prior reactions to antipsychotics such as neuroleptic malignant syndrome (NMS) or tardive dyskinesia. Risperdal can cause orthostatic hypotension (dizziness upon standing), so rise slowly and report fainting. It may impair thermoregulation; stay hydrated and avoid overheating. Use caution with activities requiring alertness until you know how you respond, as sedation can occur.
Metabolic effects—weight gain, increased cholesterol, and elevated blood sugar—can occur; baseline and periodic monitoring of weight, waist circumference, blood pressure, fasting lipids, and glucose/A1C is recommended. Risperdal can elevate prolactin, potentially causing menstrual changes, breast enlargement or tenderness, galactorrhea, or sexual dysfunction. In elderly patients with dementia-related psychosis, antipsychotics are associated with increased risk of death and cerebrovascular events; risperidone is not approved for this population. Discuss pregnancy, plans to become pregnant, and breastfeeding with your clinician; antipsychotic decisions require individualized risk–benefit assessment.
Risperdal is contraindicated in patients with known hypersensitivity to risperidone or formulation excipients. It carries a boxed warning for increased mortality in elderly patients with dementia-related psychosis and should not be used for this indication. Use extreme caution or consider alternatives in individuals with a history of severe EPS, tardive dyskinesia, or neuroleptic malignant syndrome, and in those with significant cardiovascular disease, severe hepatic or renal impairment, or uncontrolled seizure disorders. Always review your full medication list and medical history with a prescriber before starting therapy.
Common side effects include drowsiness or fatigue, dizziness, increased appetite, weight gain, dry mouth, constipation, nasal congestion, and gastrointestinal upset. Some individuals experience extrapyramidal symptoms such as restlessness (akathisia), muscle stiffness, tremor, or slowness of movement, especially at higher doses or when combined with other dopamine-blocking agents. Orthostatic hypotension can lead to lightheadedness or fainting, particularly when first starting or during dose increases.
Metabolic changes—elevated blood glucose, dyslipidemia, and increased waist circumference—are clinically significant and warrant monitoring. Risperdal may increase prolactin, leading to menstrual irregularities, infertility, decreased libido, erectile dysfunction, gynecomastia, or galactorrhea. Less common but serious effects include neuroleptic malignant syndrome (fever, muscle rigidity, confusion, autonomic instability), tardive dyskinesia (involuntary movements that may be irreversible), seizures, severe allergic reactions, and blood dyscrasias. Rarely, QT prolongation and arrhythmias may occur, particularly in those with underlying heart conditions or when combined with other QT-prolonging drugs. Seek urgent medical care for chest pain, severe dizziness or fainting, high fever with rigidity, uncontrollable movements, or signs of severe allergic reaction (hives, swelling, difficulty breathing).
Risperidone is metabolized by CYP2D6 and, to a lesser extent, CYP3A4. Strong CYP2D6 inhibitors (such as fluoxetine, paroxetine, quinidine, bupropion) can raise risperidone levels and increase side effects; dose adjustments or alternative therapies may be considered. CYP3A4 inducers (such as carbamazepine, phenytoin, rifampin, and St. John’s wort) can lower risperidone levels and reduce efficacy. Some HIV protease inhibitors and azole antifungals may alter exposure; close monitoring is advised.
Additive sedative effects can occur with alcohol, benzodiazepines, opioids, antihistamines, or other CNS depressants. Combining Risperdal with other dopamine antagonists (e.g., metoclopramide, certain antipsychotics) increases the risk of EPS and tardive dyskinesia. Caution is warranted with medications that prolong the QT interval (certain antiarrhythmics, macrolide antibiotics, fluoroquinolones, methadone). Antihypertensives may have enhanced blood pressure–lowering effects when used with risperidone. Valproate can alter free risperidone fractions; clinical monitoring is recommended. Always review all prescriptions, OTC drugs, supplements, and herbal products with your healthcare provider.
If you miss an oral dose of Risperdal, take it as soon as you remember unless it is close to your next scheduled dose. If it is almost time for the next dose, skip the missed dose and resume your regular schedule. Do not double up to “catch up,” as this may increase side effects without improving efficacy. Consistency supports symptom control, so consider using reminders or a pill organizer. If you receive a long-acting injectable formulation and miss an injection appointment, contact your clinic promptly for individualized instructions; do not attempt to self-administer injections or adjust your schedule independently.
Risperdal overdose can cause pronounced drowsiness or sedation, rapid heart rate, low blood pressure, dizziness, vomiting, extrapyramidal symptoms, and, in severe cases, cardiac arrhythmias, seizures, or altered consciousness. If an overdose is suspected, call your local emergency number and Poison Control right away. Do not induce vomiting unless instructed by medical personnel. Emergency clinicians may provide supportive care, cardiac and respiratory monitoring, IV fluids for hypotension, and management of EPS or arrhythmias. Bring the medication bottle or list of medicines to the healthcare team to facilitate rapid, accurate treatment.
Store tablets and orally disintegrating tablets at controlled room temperature (generally 68–77°F or 20–25°C), protected from moisture and light, in the original container with the lid tightly closed. Keep the orally disintegrating tablets in their blister until use. The oral solution should remain tightly capped; consult the label for any specific temperature instructions and do not freeze. Keep all forms of Risperdal out of reach of children and pets. Do not use medication past its expiration date. For disposal, use community medication take-back programs or follow FDA/DEA guidance; do not flush unless specifically directed.
In the United States, Risperdal (risperidone) is a prescription-only medication. It cannot be legally purchased without a valid prescription from a licensed clinician who has evaluated your condition. Claims that you can buy Risperdal without prescription are misleading and may be unsafe. HealthSouth Rehabilitation Hospital of Tallahassee does not sell medications directly to consumers or bypass prescription requirements; instead, it offers structured, legal care pathways—evaluation by licensed providers, diagnosis, and when appropriate, a legitimate prescription sent to a licensed pharmacy. This approach ensures clinical oversight, accurate dosing, drug–interaction screening, and ongoing monitoring of side effects and treatment response.
If you think Risperdal might be right for you, schedule a medical consultation. Many patients can be evaluated through in-person visits or compliant telehealth services. After assessment, your clinician will discuss risks, benefits, alternatives, and monitoring plans, and can coordinate pharmacy fulfillment. To protect your health and privacy, avoid unverified online sellers or services that offer prescription medicines without a clinical evaluation; these may provide counterfeit or unsafe products. Choosing a legal, supervised pathway helps you receive effective, individualized care and rapid support if side effects or questions arise.
1 Risperdal is an atypical antipsychotic used to treat certain mental health conditions. It blocks dopamine D2 and serotonin 5‑HT2A receptors, helping rebalance brain signaling that drives symptoms like hallucinations, delusions, mood swings, aggression, and irritability.
2 Risperdal is FDA‑approved for schizophrenia in adults and adolescents, acute manic or mixed episodes in bipolar I disorder (alone or with mood stabilizers), and irritability associated with autistic disorder in children and adolescents. It is not approved for dementia‑related psychosis.
3 Some people notice reduced agitation and improved sleep within a few days. Psychosis and mood symptoms often start improving in 1–2 weeks, with full benefits building over 4–6 weeks or longer, depending on dose, diagnosis, and individual response.
4 Risperdal comes as standard tablets, orally disintegrating tablets (M‑Tab), an oral solution, and long‑acting injections (Risperdal Consta every 2 weeks; Perseris once monthly). It is usually taken once or twice daily with or without food; your dose is individualized and titrated slowly.
5 Common effects include sleepiness, dizziness, increased appetite, weight gain, dry mouth, constipation, nausea, restlessness/akathisia, and muscle stiffness or tremor. Many are dose‑related and can often be managed by adjusting dose or timing.
6 Serious but uncommon risks include neuroleptic malignant syndrome, tardive dyskinesia, significant increases in prolactin, metabolic syndrome (high blood sugar and lipids), orthostatic hypotension, seizures, and QT prolongation. There is a boxed warning for increased death risk in elderly patients with dementia‑related psychosis.
7 Yes, risperidone has a moderate risk for weight gain and changes in blood sugar and cholesterol. Baseline and periodic checks of weight, waist circumference, fasting glucose/A1c, and lipids plus lifestyle measures (diet, activity, sleep) help reduce risk.
8 Risperdal commonly elevates prolactin, which can cause decreased libido, erectile dysfunction, irregular periods, missed periods, breast tenderness, and milk production. Let your clinician know if these occur; dose adjustment or switching medications can help.
9 Typical monitoring includes weight/BMI and waist, fasting glucose or A1c, lipids, blood pressure, and movement exams (for EPS and tardive dyskinesia). Prolactin is checked if symptoms arise, and an EKG may be considered if you have cardiac or QT risk factors.
10 Strong CYP2D6 inhibitors (like fluoxetine, paroxetine) can raise risperidone levels; enzyme inducers (like carbamazepine, some anti‑seizure meds, St. John’s wort) can lower them. Additive sedation with alcohol, benzodiazepines, or opioids is possible, and combining with QT‑prolonging drugs needs caution.
11 No. Risperdal is not approved for behavioral problems in dementia and carries an increased risk of death and stroke in this population. Non‑drug measures are preferred; if medication is considered, it must be carefully weighed and closely monitored.
12 Yes, for certain diagnoses and ages: schizophrenia (adolescents), bipolar I mania (children and adolescents), and irritability in autism (children and adolescents). Growth, weight, metabolic labs, movement symptoms, and prolactin‑related effects require close monitoring.
13 Alcohol and cannabis can increase drowsiness, impair coordination and judgment, and worsen dizziness or orthostatic drops in blood pressure. Avoid or limit use and be cautious with activities like driving until you know how you respond.
14 Take the missed dose when you remember unless it’s close to the next dose—then skip and resume your regular schedule. Don’t double up. If you miss an injection, contact your clinic promptly to reschedule.
15 Yes. Risperdal Consta is an intramuscular injection given every 2 weeks and typically requires about 3 weeks of oral overlap. Perseris is a once‑monthly subcutaneous injection that usually does not require oral overlap.
16 Both treat schizophrenia and bipolar I. Abilify, a partial dopamine agonist, tends to cause less weight gain and often lowers prolactin, but it can cause activation and akathisia. Risperdal has a higher prolactin and EPS risk but may be more calming for agitation.
17 Seroquel is typically more sedating, with lower EPS and prolactin effects but higher risk of weight gain and metabolic issues. Risperdal is less sedating, with more prolactin elevation and possible stiffness or restlessness. Choice often hinges on sedation needs and metabolic risk.
18 Olanzapine generally causes more weight gain and metabolic side effects than risperidone. Risperdal has a higher likelihood of prolactin elevation and EPS at higher doses, while olanzapine is more sedating.
19 Ziprasidone has lower risk of weight gain but a higher propensity for QT prolongation and must be taken with a substantial meal for absorption. Risperdal more often raises prolactin and can cause EPS. Cardiac history and metabolic priorities often guide the choice.
20 Paliperidone is the major active metabolite of risperidone, so efficacy and side‑effect profiles are similar, including prolactin elevation. Paliperidone is primarily renally cleared and less affected by CYP2D6 differences, and it has multiple long‑acting injection options.
21 Lurasidone generally has a more favorable metabolic profile and minimal prolactin effects but can cause akathisia or stiffness. It must be taken with at least 350 calories. Risperdal has more prolactin elevation and moderate metabolic risk but can be less activating.
22 Haloperidol, a first‑generation antipsychotic, carries a higher risk of EPS and tardive dyskinesia but tends to have less weight gain. Both can raise prolactin. For long‑term treatment, many clinicians prefer risperidone for its broader receptor profile and mood benefits.
23 Clozapine is reserved for treatment‑resistant schizophrenia or to reduce recurrent suicidal behavior in schizophrenia/schizoaffective disorder. It often works when others fail but requires stringent blood monitoring and carries significant risks (agranulocytosis, seizures, myocarditis, major metabolic effects).
24 Both are effective for acute mania. Cariprazine, a D3‑preferring partial agonist, has lower prolactin and weight gain risk but more akathisia and insomnia and a very long half‑life. Risperdal acts faster for some patients with agitation and is widely used acutely.
25 Brexpiprazole is a serotonin‑dopamine modulator with generally mild prolactin effects, moderate weight gain, and lower activation than aripiprazole. Risperdal more commonly raises prolactin and can cause EPS at higher doses. Brexpiprazole is also used as adjunct therapy in depression.
26 Risperdal Consta is IM every 2 weeks with oral overlap; Perseris is monthly subcutaneous without overlap. Invega Sustenna (paliperidone) is monthly IM with a loading regimen and no oral overlap, followed by 2‑ or 3‑month options (Trinza/Hafyera). Choice depends on interval preferences, sites, and individual response.
27 Most switches use cross‑titration: gradually start and increase the new medication while slowly tapering Risperdal, monitoring for relapse, withdrawal insomnia or agitation, EPS, and side effects. The schedule is individualized based on diagnosis, current dose, and target drug.